Clinical Trials Browser

Phase 1/2 × lucatumumab × Clear all

NCT00670592 2020-12-17

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

Phase 1/2 Completed

Hodgkin Disease, Lymphoma, Non-Hodgkin